Register by January 25th and save up to $400!

click here to view a list of Alliance Management Alumni

Thursday, April 10

MAIN CONFERENCE 

7:30 am Registration, Morning Coffee, and One-to-One Meetings

8:30 Chairperson’s Opening Remarks & Interactive Large Group Discussion
Stuart Kliman, J.D., Head, Pharmaceuticals Practice Area, Vantage Partners

9:15 ‘Point-Counterpoint’: Where or in Which Function Does the Alliance Management Responsibility Reside? Where and in which function the Alliance Management responsibility resides depends on organizational needs, size, culture, personnel, and a whole host of other considerations. We will debate the issues and pros/cons of alliance management residing in business development, in project management or being a stand-alone function. Those with one particular mindset will be provided a window of more options to consider, as well as more flexible perspectives in working with their alliance partners. Mauri Okamoto-Kearney, Product Development & New Product  Planning, KAI Pharmaceuticals, Inc. Andrew Eibling, Ph.D., Alliance Manager, Eli Lilly and Company Ailsa Mendez, MBA, Director Project Governance, Functional Genetics

10:30 Networking Coffee Break and One-to-One Meetings

11:00 Alliance Management and Project Management: A Successful Partnership
This session presents a case where a pharmaceutical company entered into an alliance with a small biotech to develop and commercialize a novel pharmaceuti-cal. The smaller firm, with the agreement of its larger partner, contracted a professional third-party project manager to lead the project and serve as a bridge be-tween the companies. This talk will describe how alliance management and project management worked together to facilitate communication, build trust and allay concerns. 
Mary Jo Struttmann, MBA, Senior Director, Alliance Mgmt, Astellas US, LLC
Rick Boardman, Ph.D., Project Manager, Integrated Project Management Company, Inc. 

11:45 Alliance Management & Project Management: The Seamless Transition
Project Management and Alliance Management play two different, yet similar roles as it relates to a pending partnership. This session will examine the different phases of a recent international commercialization agreement from the perspective of both departments. Depending on the time frame, one or both departments had a very active role in the daily aspects of the agreement. Solstice Neurosciences has realized the ability to maximize the value of their alliances through strong collaboration between the Project and Alliance Management departments. 
Michelle Shaw, Director, Alliance Management, Solstice Neurosciences, Inc.

12:15 pm How Does Business Development/Licensing Interface with Alliance Management?
Lilly’s framework for sourcing innovation is represented by its “find it - get it - create value” model. This model pairs the business development and alliance management functions early in the process, driving alignment discussions that benefit both functions, and more importantly the potential partner. This process will be reviewed and some examples will be discussed. 
Michael Ransom, Manager, Alliance Management Operations, Eli Lilly Company

12:45 Lunch On Your Own (Sponsorship Available)

2:00 Alliance Governance: Strategic Recommendations for Contracting and Re-Negotiating Contracts
Good contracts are essential parts of all alliances, whether they are formal and detailed descriptions of responsibilities and rights, or informal ones providing a shared understanding of the alliance purpose and operation. A key element of a good contract is getting it right during the contracting phase of the relationship, before handing the alliance over to the Alliance Management function to manage and make successful. This presentation will explore the governance of business development/licensing interface with alliance management from the businessperson’s strategic perspective, not the lawyer’s perspective.
Harry Atkins, Senior Director, Alliance Management, Endo Pharmaceuticals, Inc.

2:30 Pharmacovigilance and Labeling in Alliances
Pharmacovigilance and labeling responsibilities can be easily overlooked in alliances and in doing so can ultimately hurt the alliance. Parties need to understand the implications of ignoring pharmacovigilance and/or labeling in regards to Alliances. This talk will describe the role of pharmacovigilance and labeling in alliance agreements and provide examples of what can happen when pharmacovigilance and/or labeling are not addressed or addressed adequately in alliance agreements. 
Vikki Hurley, Director Contractual Agreements, Pharmacovigilance, Wyeth

3:00 Networking Refreshment Break and One-to-One Meetings

3:15 How Do You Start an Alliance Management Team?
Alliance teams are central to the management of the joint corporate asset and their formation and management are one of the keys to success of the project objectives. All Team members must understand the key objectives for both companies entering the alliance and what competitive advantages and skill sets each partner brings. Two case studies will be presented that will describe the formation and performance measurement of alliance teams. 
Ailsa Mendez, MBA, Director Project Governance, Functional Genetics
Katya Kovalskaia, PMP, Project Manager, MedImmune

3:45 Network Collaboration Management – An Emerging Model of Alliance Management Design 
An evolution of the alliance management function is emerging in organizations where partnering across the business is essential to strategy. As more and more companies turn to partnering as a core element of their strategy, managing all these relationships well becomes a core competency. Collaborative network management right-sizes and applies principles of alliance management to outsourcing, distribution, and supply chain partners, resulting in a consistent strategic framework for managing all key external relationships. This session offers insights into this emerging model, as well as the challenges of designing and implementing it that are useful to any organization launching, formalizing, or rethinking its alliance management function. 
Jeffrey Shuman, Ph.D., Principal, The Rhythm of Business, Inc., Professor of Management, Bentley College
Janice Twombly, Principal, The Rhythm of Business, Inc. 

4:30 Interactive Breakout Discussions & Report Outs
Concurrent roundtables to discuss some of the more broad yet poignant questions facing the industry. Each roundtable will be limited to twelve (12) participants and a facilitator.

6:00 Networking Cocktail Reception and One-to-One Meetings

7:00 Close of Day

Pre Con - Day 2